论文部分内容阅读
肾细胞癌(RCC)是泌尿系统常见的恶性肿瘤,早期可行手术根治性切除,晚期对放化疗均不敏感。随着肿瘤生物治疗的研究,晚期RCC的免疫治疗取得了许多实质性的进展。本文综述近年晚期RCC免疫治疗的临床研究进展。
Renal cell carcinoma (RCC) is a common malignant tumor of the urinary system. Radical resection is feasible in the early stage and is not sensitive to radiotherapy and chemotherapy in the late stage. With the study of tumor biotherapy, many substantial advances have been made in the immunotherapy of advanced RCC. This review summarizes the progress of RCC immunotherapy in recent years.